Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWise Group Regulatory News (WISE)

Share Price Information for Wise Group (WISE)

Share Price is delayed by 15 minutes
Get Live Data
788.00    -4.00 (-0.51%)
Bid:
786.00
Ask:
790.00
Spread: 4.00 (0.509%)
Market Cap: £7.88b
WISE Live PriceLast checked at - London Stock Exchange

Intraday Wise Group Share Chart

Wise plc American Depositary Receipt Program

18 Aug 2021 14:00

RNS Number : 0696J
Wise PLC
18 August 2021
 

Wise plc

18 August 2021

 

Wise plc American Depositary Receipt Program

 

Wise plc (LON: WISE) is pleased to announce it has taken steps today to establish a level 1 American Depositary Receipt (ADR) program in the US by filing a registration statement on Form F-6 with the US Securities and Exchange Commission. It is expected that Wise's ADRs will begin trading on the over-the-counter (OTC) market on 8 September 2021, under a ticker symbol that will be announced closer to the program's effective date.

The ADR program will complement Wise's existing primary listing on the London Stock Exchange. One Wise ADR will represent one underlying Wise class A ordinary share.

The ADR program does not involve the issuance of new shares or the raising of new capital by Wise.

ADRs allow US investors to buy shares in foreign companies without the need for cross-border or cross-currency transactions. They are priced in US dollars and can be traded like shares of US-based companies listed on the OTC market.

J.P. Morgan has been appointed as the depositary bank for the Level 1 ADR program. 

 

Further information

 

For further information on this update or the Company generally, please visit our website at www.wise.com/owners or see full contact details at the end of this release.

A copy of this announcement is available from the Company's website at www.wise.com/owners.

The Board of Directors of Wise authorised this announcement to be given to the London Stock Exchange.

 

Enquiries

 

Martin Adams - Head of Owner Relations

martin.adams@wise.com

Abigail Daniels - Head of Public Relations

press@wise.com

 

Brunswick Group 

Charles Pretzlik / Sarah West / Samantha Chiene 

Wise@brunswickgroup.com 

+44 (0) 20 7404 5959

 

About Wise

 

Wise is a global technology company, building the best way to move money around the world. With the Wise account people and businesses can hold 56 currencies, move money between countries and spend money abroad. Large companies and banks use Wise technology too; an entirely new cross-border payments network that will one day power money without borders for everyone, everywhere. However you use the platform, Wise is on a mission to make your life easier and save you money.

 

Co-founded by Kristo Käärmann and Taavet Hinrikus, Wise launched in 2011 under its original name TransferWise. It is one of the world's fastest growing, profitable tech companies and is listed on the London Stock Exchange under the ticker, WISE.

 

10 million people and businesses use Wise, which processes over £5 billion in cross-border transactions every month, saving customers over £1 billion a year.

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKFBDBBKDNFD
Date   Source Headline
18th Jul 20231:59 pmRNSDirector/PDMR Shareholding
18th Jul 20237:00 amRNSWise Plc Q1FY24 Trading Update
4th Jul 20233:22 pmRNSAnnual Financial Report
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 20234:00 pmRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSWise plc Preliminary Results FY end 31 March 2023
15th Jun 20237:00 amRNSDirector/PDMR Shareholding
2nd Jun 20239:47 amRNSTotal Voting Rights
22nd May 20237:00 amRNSManagement Update
15th May 202312:31 pmRNSDirector/PDMR Shareholding
10th May 20239:30 amRNSManagement update
2nd May 20233:24 pmRNSDirector/PDMR Shareholding
2nd May 20237:00 amRNSTotal Voting Rights
25th Apr 20237:00 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSDirector/PDMR Shareholding
19th Apr 20237:00 amRNSBoard Appointments
18th Apr 20237:00 amRNSWise Plc Q4 FY23 Trading Update
3rd Apr 202311:26 amRNSDirector/PDMR Shareholding
31st Mar 202312:47 pmRNSTotal Voting Rights
21st Mar 202311:24 amRNSTotal Voting Rights (Replacement)
21st Mar 202311:11 amRNSTotal Voting Rights (Replacement)
21st Mar 202310:40 amRNSTotal Voting Rights (Replacement)
24th Feb 20239:55 amRNSHolding(s) in Company
24th Feb 20237:00 amRNSHolding(s) in Company
23rd Feb 20232:43 pmRNSTotal Voting Rights
10th Feb 20232:22 pmRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSAdditional Listing
6th Feb 202310:53 amRNSDirector/PDMR Shareholding
1st Feb 202311:13 amRNSTotal Voting Rights
18th Jan 20234:17 pmRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSWise Plc Q3 FY23 Trading Update
3rd Jan 20237:00 amRNSTotal Voting Rights
20th Dec 20224:08 pmRNSGrant of Awards to CFO
8th Dec 20225:45 pmRNSHolding(s) in Company
5th Dec 202210:09 amRNSHolding(s) in Company
2nd Dec 20229:48 amRNSDirector/PDMR Shareholding
30th Nov 202212:10 pmRNSTotal Voting Rights
29th Nov 20227:00 amRNSWise Plc HY FY23 Interim Results
4th Nov 20222:16 pmRNSDirector/PDMR Shareholding
31st Oct 202210:31 amRNSTotal Voting Rights
21st Oct 202210:19 amRNSDirector/PDMR Shareholding
18th Oct 20227:00 amRNSStrong momentum in Q2, supports outlook for year
5th Oct 202212:06 pmRNSAdditional Listing
5th Oct 20229:00 amRNSAdditional Listing
29th Sep 20222:30 pmRNSGrowth momentum continues; guidance upgraded
23rd Sep 202212:29 pmRNSNotice of Results
22nd Sep 202210:29 amRNSHolding(s) in Company
22nd Sep 202210:18 amRNSAllotment of OwnWise Shares
13th Sep 202210:21 amRNSHolding(s) in Company
12th Sep 20223:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.